Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P K Narang

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Archives of General Psychiatry|February 1, 1987
Clinical and biochemical effects of verapamil administration to schizophrenic patientsD Pickar, O M Wolkowitz, A R Doran, et al.
Drug and Alcohol Dependence|December 2, 1996
Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug usersL S Brown, R C Sawyer, R Li, et al.
Biopharmaceutics & Drug Disposition|August 1, 1996
Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogsJ R Baldwin, R C Lewis, B A Phillips, et al.
Journal of Clinical Pharmacology|April 1, 1993
A phase I dose-ranging safety and pharmacokinetics study of a novel oral thromboxane synthase inhibitor, FCE 22, 178R C Li, P K Narang, R C Lewis, et al.
Epilepsia|September 1, 1985
Chronic carbamazepine treatment increases brain adenosine receptorsP J Marangos, S R Weiss, P Montgomery, et al.
Psychoneuroendocrinology|January 1, 1990
Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's diseaseP A Newhouse, T Sunderland, P K Narang, et al.
Journal of Neural Transmission|January 1, 1987
Lack of effect of chronic carbamazepine on brain somatostatin in the ratS R Weiss, T Nguyen, D R Rubinow, et al.
American Heart Journal|December 1, 1979
Quinidine therapy in hospitalized patients with ventricular arrhythmiasN H Carliner, W G Crouthamel, M L Fisher, et al.
Cancer Research|November 15, 1991
Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic studyP C Adamson, F M Balis, C A Arndt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1997
Phase I study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762, PNU 152243) administered on a daily x3 scheduleM J Ratain, L A Skoog, S M O'Brien, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Archives of General Psychiatry|February 1, 1987
Clinical and biochemical effects of verapamil administration to schizophrenic patientsD Pickar, O M Wolkowitz, A R Doran, et al.
Drug and Alcohol Dependence|December 2, 1996
Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug usersL S Brown, R C Sawyer, R Li, et al.
Biopharmaceutics & Drug Disposition|August 1, 1996
Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogsJ R Baldwin, R C Lewis, B A Phillips, et al.
Journal of Clinical Pharmacology|April 1, 1993
A phase I dose-ranging safety and pharmacokinetics study of a novel oral thromboxane synthase inhibitor, FCE 22, 178R C Li, P K Narang, R C Lewis, et al.
Epilepsia|September 1, 1985
Chronic carbamazepine treatment increases brain adenosine receptorsP J Marangos, S R Weiss, P Montgomery, et al.
Psychoneuroendocrinology|January 1, 1990
Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's diseaseP A Newhouse, T Sunderland, P K Narang, et al.
Journal of Neural Transmission|January 1, 1987
Lack of effect of chronic carbamazepine on brain somatostatin in the ratS R Weiss, T Nguyen, D R Rubinow, et al.
American Heart Journal|December 1, 1979
Quinidine therapy in hospitalized patients with ventricular arrhythmiasN H Carliner, W G Crouthamel, M L Fisher, et al.
Cancer Research|November 15, 1991
Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic studyP C Adamson, F M Balis, C A Arndt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1997
Phase I study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762, PNU 152243) administered on a daily x3 scheduleM J Ratain, L A Skoog, S M O'Brien, et al.
Pageof 6